Evolution of anti-SARS-CoV-2 immune response in a cohort of French healthcare workers followed for 7 months

Chou, 2020, Epidemiology of and risk factors for coronavirus infection in health care workers: a living rapid review, Ann Intern Med, 173, 120, 10.7326/M20-1632 Fafi-Kremer, 2020, Serologic responses to SARS-CoV-2 infection among hospital staff with mild disease in eastern France, EBioMedicine, 59, 102915, 10.1016/j.ebiom.2020.102915 Lumley, 2021, Antibody status and incidence of SARS-CoV-2 infection in health care workers, N Engl J Med, 384, 533, 10.1056/NEJMoa2034545 Garcia-Basteiro, 2020, Seroprevalence of antibodies against SARS-CoV-2 among health care workers in a large Spanish reference hospital, Nat Commun, 11, 3500, 10.1038/s41467-020-17318-x Houlihan, 2020, Pandemic peak SARS-CoV-2 infection and seroconversion rates in London frontline health-care workers, Lancet Lond Engl, 396, 6, 10.1016/S0140-6736(20)31484-7 Deeks, 2020, Antibody tests for identification of current and past infection with SARS-CoV-2, Cochrane Database Syst Rev, 6 National SARS-CoV-2 Serology Assay Evaluation Group, 2020, Performance characteristics of five immunoassays for SARS-CoV-2: a head-to-head benchmark comparison, Lancet Infect Dis, 20, 1390, 10.1016/S1473-3099(20)30634-4 Wellinghausen, 2020, SARS-CoV-2-IgG response is different in COVID-19 outpatients and asymptomatic contact persons, J Clin Virol Off Publ Pan Am Soc Clin Virol, 130, 104542, 10.1016/j.jcv.2020.104542 Xiang, 2020, Antibody detection and dynamic characteristics in patients with Coronavirus Disease 2019, Clin Infect Dis Off Publ Infect Dis Soc Am, 71, 1930, 10.1093/cid/ciaa461 To, 2020, Temporal profiles of viral load in posterior oropharyngeal saliva samples and serum antibody responses during infection by SARS-CoV-2: an observational cohort study, Lancet Infect Dis, 20, 565, 10.1016/S1473-3099(20)30196-1 Legros, 2021, A longitudinal study of SARS-CoV-2-infected patients reveals a high correlation between neutralizing antibodies and COVID-19 severity, Cell Mol Immunol, 10.1038/s41423-020-00588-2 Dhama, 2020, COVID-19, an emerging coronavirus infection: advances and prospects in designing and developing vaccines, immunotherapeutics, and therapeutics, Hum Vaccines Immunother, 16, 1232, 10.1080/21645515.2020.1735227 Guo, 2020, Profiling early humoral response to diagnose novel Coronavirus Disease (COVID-19), Clin Infect Dis Off Publ Infect Dis Soc Am, 71, 778, 10.1093/cid/ciaa310 Nalbandian, 2021, Post-acute COVID-19 syndrome, Nat Med, 27, 601, 10.1038/s41591-021-01283-z Wyllie, 2020, SARS-CoV-2 responsive T cell numbers are associated with protection from COVID-19: A prospective cohort study in keyworkers, Infectious Diseases (except HIV/AIDS) Ma, 2020, Cross-reactivity towards SARS-CoV-2: the potential role of low-pathogenic human coronaviruses, Lancet Microbe, 1, 151, 10.1016/S2666-5247(20)30098-7 Isa, 2002, Comparison of immunoglobulin G subclass profiles induced by measles virus in vaccinated and naturally infected individuals, Clin Diagn Lab Immunol, 9, 693 Long, 2020, Antibody responses to SARS-CoV-2 in COVID-19 patients: the perspective application of serological tests in clinical practice, MedRxiv Lee, 2020, Dynamics of anti-SARS-Cov-2 IgM and IgG antibodies among COVID-19 patients, J Infect, 81, 55, 10.1016/j.jinf.2020.04.019 Breathnach, 2021, Prior COVID-19 significantly reduces the risk of subsequent infection, but reinfections are seen after eight months, J Infect, 10.1016/j.jinf.2021.01.005 Bao, 2021, Dynamic anti-spike protein antibody profiles in COVID-19 patients, Int J Infect Dis IJID Off Publ Int Soc Infect Dis, 103, 540 Long, 2020, Antibody responses to SARS-CoV-2 in patients with COVID-19, Nat Med, 26, 845, 10.1038/s41591-020-0897-1 Okba, 2020, Severe acute respiratory syndrome Coronavirus 2-specific antibody responses in coronavirus disease patients, Emerg Infect Dis, 26, 1478, 10.3201/eid2607.200841 Dan, 2021, Immunological memory to SARS-CoV-2 assessed for up to 8 months after infection, Science, 371 Marot, 2021, Rapid decline of neutralizing antibodies against SARS-CoV-2 among infected healthcare workers, Nat Commun, 12, 844, 10.1038/s41467-021-21111-9 Wajnberg, 2020, Robust neutralizing antibodies to SARS-CoV-2 infection persist for months, Science, 370, 1227, 10.1126/science.abd7728 Zhang, 2020, Viral and antibody kinetics of COVID-19 patients with different disease severities in acute and convalescent phases: a 6-month follow-up study, Virol Sin, 35, 820, 10.1007/s12250-020-00329-9 Liang, 2020, Three-month follow-up study of survivors of coronavirus disease 2019 after discharge, J Korean Med Sci, 35, 418, 10.3346/jkms.2020.35.e418 Long, 2020, Clinical and immunological assessment of asymptomatic SARS-CoV-2 infections, Nat Med, 26, 1200, 10.1038/s41591-020-0965-6 Hanrath, 2020, Prior SARS-CoV-2 infection is associated with protection against symptomatic reinfection, J Infect Chopra, 2020, Sixty-day outcomes among patients hospitalized with COVID-19, Ann Intern Med Arnold, 2020, Patient outcomes after hospitalisation with COVID-19 and implications for follow-up: results from a prospective UK cohort, Thorax